Synonyms: GSK-2398852 | GSK2398852
Compound class:
Antibody
Comment: Dezamizumab (GSK2398852) is an anti-human serum amyloid P component (anti-SAP) monoclonal antibody, being developed by GlaxoSmithKline as a potential therapy for the rare disease amyloidosis.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10364 | dezamizumab |
Synonyms ![]() |
GSK-2398852 | GSK2398852 |
Database Links ![]() |
|
GtoPdb PubChem SID | 249565935 |
Search PubMed clinical trials | dezamizumab |
Search PubMed titles | dezamizumab |
Search PubMed titles/abstracts | dezamizumab |